BriaCell Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.

About BCTX

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer.

CEO

William V. Williams

CEOWilliam V. Williams

Employees

Employees18

Headquarters

West Vancouver, British Columbia

HeadquartersWest Vancouver, British Columbia

Founded

2006

Founded2006

Employees

Employees18

BCTX Key Statistics

Market cap

22.78M

Market cap22.78M

Price-Earnings ratio

-1.21

Price-Earnings ratio-1.21

Dividend yield

—

Dividend yield—

Average volume

6.30M

Average volume6.30M

High today

$12.27

High today$12.27

Low today

$5.44

Low today$5.44

Open price

$9.36

Open price$9.36

Volume

40.71M

Volume40.71M

52 Week high

$36.60

52 Week high$36.60

52 Week low

$3.00

52 Week low$3.00

BCTX News

Benzinga 14h

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

BriaCell Therapeutics Corp. BCTX confirmed on Thursday that it has sustained a complete resolution of the lung metastasis, first reported in February 2025, two...